BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16603200)

  • 1. Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action.
    Hu QW; Liu GT
    Life Sci; 2006 Jul; 79(6):606-12. PubMed ID: 16603200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats].
    Zhao XY; Wang BE; Wang TL; Li XM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2563-6. PubMed ID: 17198567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-fibrotic effects of the anthocyanins isolated from the purple-fleshed sweet potato on hepatic fibrosis induced by dimethylnitrosamine administration in rats.
    Choi JH; Hwang YP; Choi CY; Chung YC; Jeong HG
    Food Chem Toxicol; 2010 Nov; 48(11):3137-43. PubMed ID: 20728498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The flavonoid quercetin inhibits dimethylnitrosamine-induced liver damage in rats.
    Lee ES; Lee HE; Shin JY; Yoon S; Moon JO
    J Pharm Pharmacol; 2003 Aug; 55(8):1169-74. PubMed ID: 12956909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
    Wang H; Li Y
    Eur J Pharmacol; 2006 Mar; 534(1-3):194-201. PubMed ID: 16487963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective effects of bicyclol on liver fibrosis induced by carbon tetrachloride].
    Li Y; Li Y; Liu GT
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2096-101. PubMed ID: 15730626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamic evolution of MMP-13, TIMP-1, type I and III collagen and their interaction in experimental liver fibrosis].
    Zhu YK; Wang BE; Shen FJ; Wang AM; Jia JD; Ma H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):612-5. PubMed ID: 15504294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of bicyclol on acute alcohol-induced liver injury in mice.
    Zhao J; Chen H; Li Y
    Eur J Pharmacol; 2008 May; 586(1-3):322-31. PubMed ID: 18371952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
    Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
    Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bicyclol on immunological liver fibrosis in rats.
    Gu Y; Zhao J; Yao XM; Li Y
    J Asian Nat Prod Res; 2010 May; 12(5):388-98. PubMed ID: 20496196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats.
    Nakamura T; Sakata R; Ueno T; Sata M; Ueno H
    Hepatology; 2000 Aug; 32(2):247-55. PubMed ID: 10915731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
    Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
    J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of corydyceps polysaccharide on liver fibrosis induced by DMN in rats].
    Li FH; Liu P; Xiong WG; Xu GF
    Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1968-71. PubMed ID: 17348192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis.
    Matsuda Y; Matsumoto K; Yamada A; Ichida T; Asakura H; Komoriya Y; Nishiyama E; Nakamura T
    Hepatology; 1997 Jul; 26(1):81-9. PubMed ID: 9214455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of angiotensin II type 1 receptor blocker valsartan in preventing hepatic fibrosis induced by dimethylnitrosamine in rats].
    Shen FJ; Zhu YK; Jia JD; Ma H; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):605-8. PubMed ID: 15504291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats.
    Yasuda H; Imai E; Shiota A; Fujise N; Morinaga T; Higashio K
    Hepatology; 1996 Sep; 24(3):636-42. PubMed ID: 8781336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
    Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
    Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol inhibits dimethylnitrosamine-induced hepatic fibrosis in rats.
    Lee ES; Shin MO; Yoon S; Moon JO
    Arch Pharm Res; 2010 Jun; 33(6):925-32. PubMed ID: 20607498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats.
    Hong SW; Jung KH; Zheng HM; Lee HS; Suh JK; Park IS; Lee DH; Hong SS
    Arch Pharm Res; 2010 Apr; 33(4):601-9. PubMed ID: 20422370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.